TREE NEWS reports: Perrigo reported third-quarter net sales of $988.6 million, topping the $985 million estimate, with adjusted continuing-operations earnings per share of $0.60 versus $0.51 expected. The healthcare company guided full-year adjusted continuing-operations EPS to a range of $2.25 to $2.45.
Perrigo Q3 net sales $988.6M, adjusted EPS $0.60
AI take
The headline beat is modest on sales but wide on adjusted EPS, suggesting the margin story mattered more than volume this quarter. The full-year adjusted EPS range now becomes the anchor: it frames how much of the third-quarter outperformance management expects to carry through versus give back. What's worth watching is whether the sales line keeps pace with the earnings beat, since a repeat of that gap would point to cost-driven results rather than demand.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
11m ago
Ford October US Sales Fall 0.8% to 174,123 Vehicles
23m ago
Dow futures surge over 1,100 points as Democrats win US midterm elections
26m ago
Nearly 180 New Brands Enter Tmall Double 11 Top 10 Lists, Mostly Chinese
33m ago
Dow futures rise 2%, S&P 500 futures up 1.2%, Nasdaq 100 futures gain 0.4%
36m ago
European stocks extend gains; DAX up 2%, Stoxx 50 and CAC 40 up over 2%
52m ago
Qualcomm shares rise over 4% premarket as SpaceX picks it for Starlink